News

Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks
News

n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases

January 12, 2026 SDBN Comments Off on n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases

SAN DIEGO and GENEVA, Jan. 12, 2026 /PRNewswire/ — The n-Lorem Foundation and the EspeRare Foundation announced today a strategic collaboration to expand access in Europe to n-Lorem’s antisense oligonucleotide (ASO) therapies for patients with […]

News

Farm-to-Table via Supercomputer

January 12, 2026 SDBN Comments Off on Farm-to-Table via Supercomputer

Across California, researchers, farmers, technologists and universities are launching a bold vision for the future of farming: “precision agriculture,” an approach that uses advanced sensors, networking and artificial intelligence to help growers make more informed […]

No Picture
News

ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion

January 12, 2026 SDBN Comments Off on ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion

ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering Technology CARLSBAD, Calif. and FREDERICK, Md., Jan. 12, 2026 /PRNewswire/ — Alphatec Holdings, Inc. (Nasdaq: […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

BioMed Realty and TransMedics Announce 498,000-Square-Foot Lease at Assembly Innovation Park

January 12, 2026 SDBN Comments Off on BioMed Realty and TransMedics Announce 498,000-Square-Foot Lease at Assembly Innovation Park

SAN DIEGO & SOMERVILLE, Mass.–(BUSINESS WIRE)–BioMed Realty, the largest privately-owned operator of real estate for the life science and technology industries, and TransMedics Group, Inc. (“TransMedics”, ticker: TMDX), a publicly traded medical technology company transforming […]

News

Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity

January 12, 2026 SDBN Comments Off on Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity

Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in VANQUISH Phase 3 Registrational Program in Obesity SAN DIEGO, Jan. 12, […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

FairJourney Bio Launches Cryo-EM Services With Advanced Laboratories in San Diego, USA

January 12, 2026 SDBN Comments Off on FairJourney Bio Launches Cryo-EM Services With Advanced Laboratories in San Diego, USA

PORTO, Portugal and SAN DIEGO, Calif.–(BUSINESS WIRE)–FairJourney Bio (FJBio), a leading global provider of antibody discovery and development services, today announced the expansion of its portfolio with the launch of state-of-the-art cryo-electron microscopy (cryo-EM) services, […]

News

Phanes Therapeutics Announces Positive Phase 2 Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026

January 9, 2026 SDBN Comments Off on Phanes Therapeutics Announces Positive Phase 2 Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026

SAN DIEGO, Jan. 9, 2026 /PRNewswire/ — Data presented at ASCO GI 2026 show spevatamig, an anti-CLDN18.2/CD47 bsAb, in combination with chemotherapy, has the potential to be an effective first-line (1L) treatment in patients with […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Oncolytics Biotech® Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada

January 9, 2026 SDBN Comments Off on Oncolytics Biotech® Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada

SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today provided additional context regarding its previously announced proposal to change the […]

No Picture
News

Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary

January 8, 2026 SDBN Comments Off on Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in […]


ADVERTISEMENT — Advertise With Biotech Networks
News

ARDT INVESTOR ALERT: Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Ardent Health Class Action Lawsuit

January 8, 2026 SDBN Comments Off on ARDT INVESTOR ALERT: Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Ardent Health Class Action Lawsuit

SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that the Ardent Health class action lawsuit seeks to represent purchasers or acquirers of Ardent Health, Inc. (NYSE: ARDT) securities between […]


ADVERTISEMENT — Advertise With Biotech Networks
News

New Digital MSK Platform Already has 100+ Million Eligible Members and Offers Savings Upwards of 50-70% Compared to Many Other Digital MSK Offerings!

January 8, 2026 SDBN Comments Off on New Digital MSK Platform Already has 100+ Million Eligible Members and Offers Savings Upwards of 50-70% Compared to Many Other Digital MSK Offerings!

Solution Provides Self-Guided Tools Broadening Member Options for Recovery SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — American Specialty Health (ASH), a leader in musculoskeletal (MSK) health care, has launched a major enhancement to its digital […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care

January 8, 2026 SDBN Comments Off on Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care

PHILADELPHIA & CARLSBAD, Calif.–(BUSINESS WIRE)–Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that they have entered into a […]

No Picture
News

Epirium Bio Announces Follow-on Phase 1 Results in Older Adult Participants for MF-300, a First-In-Class, Oral 15-PGDH Enzyme Inhibitor, for the Treatment of Sarcopenia

January 8, 2026 SDBN Comments Off on Epirium Bio Announces Follow-on Phase 1 Results in Older Adult Participants for MF-300, a First-In-Class, Oral 15-PGDH Enzyme Inhibitor, for the Treatment of Sarcopenia

SAN DIEGO–(BUSINESS WIRE)–Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, today announced additional results from the older adult follow-on cohorts from its completed Phase 1 trial evaluating MF-300, […]

News

Aspen Neuroscience Completes Phase 1/2a ASPIRO Trial Cohort Three Dosing and State-of-the-Art Manufacturing Expansion, Paving the Way for Developing Transformative Therapies for Patients

January 8, 2026 SDBN Comments Off on Aspen Neuroscience Completes Phase 1/2a ASPIRO Trial Cohort Three Dosing and State-of-the-Art Manufacturing Expansion, Paving the Way for Developing Transformative Therapies for Patients

Facility Enters Qualification to Support Late?Stage Pivotal Manufacturing and Commercial Readiness SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — Aspen Neuroscience, Inc., a clinical?stage biotechnology company pioneering autologous regenerative therapies, today announced completion of Cohort… Click […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases

January 8, 2026 SDBN Comments Off on Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases

SAN DIEGO–(BUSINESS WIRE)–Candid Therapeutics, Inc. (“Candid”), a clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs), today announced continued clinical progress with cizutamig (BCMA TCE) and CND261 (CD20 […]

News

Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity

January 8, 2026 SDBN Comments Off on Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity

Study is Evaluating Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens Designed to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735 SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications

January 8, 2026 SDBN Comments Off on STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications

CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2026 /PRNewswire/ — STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida Biosciences […]

News

Artis BioSolutions Announces Agreement to Acquire Syngoi Technologies to Deliver Next Generation Solutions for Synthetic DNA Technology

January 7, 2026 SDBN Comments Off on Artis BioSolutions Announces Agreement to Acquire Syngoi Technologies to Deliver Next Generation Solutions for Synthetic DNA Technology

SAN DIEGO & BOSTON & BILBAO, Spain–(BUSINESS WIRE)–Artis BioSolutions (“Artis”), a San Diego-based advanced-therapies development and manufacturing company, today announced that it has entered into a definitive agreement to acquire Syngoi Technologies (“Syngoi”), a Spanish […]